DEXCOM, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
DEXCOM, INC. (DXCM) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $2.10 billion as of 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2025-02-18
- 2024-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.10B.
- 2024-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.43B.
- 2024-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.25B.
- 2023-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.07B.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2024-12-31 | $2.10B 10-K · filed 2025-02-18 | |
| 2024-06-30 | $2.43B 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $2.25B 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $2.07B 10-K · filed 2025-02-18 | |
| 2023-09-30 | $2.27B 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $2.10B 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $2.23B 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $2.13B 10-K · filed 2024-02-08 | |
| 2022-09-30 | $1.82B 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $2.26B 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $2.19B 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $2.04B 10-Q · filed 2022-10-27 | |
| 2021-09-30 | $2.14B 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $2.00B 10-Q · filed 2021-10-28 | |
| 2021-03-31 | $1.90B 10-Q · filed 2021-07-29 | |
| 2020-12-31 | $1.83B 10-Q · filed 2021-10-28 | |
| 2020-09-30 | $1.50B 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $1.35B 10-Q · filed 2021-10-28 | |
| 2020-03-31 | $934.50M 10-Q · filed 2021-07-29 | |
| 2019-12-31 | $882.60M 10-Q · filed 2021-10-28 | |
| 2019-09-30 | $764.30M 10-Q · filed 2020-10-27 | |
| 2019-06-30 | $688.30M 10-Q · filed 2020-10-27 | |
| 2019-03-31 | $668.60M 10-Q · filed 2020-07-28 | |
| 2018-12-31 | $663.30M 10-K · filed 2021-02-11 | |
| 2018-09-30 | $562.20M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $482.10M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $421.70M 10-Q · filed 2019-07-31 | |
| 2017-12-31 | $419.40M 10-K · filed 2021-02-11 | |
| 2017-09-30 | $384.00M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $353.70M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $277.80M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $283.80M 10-K · filed 2020-02-13 | |
| 2016-09-30 | $261.80M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $246.40M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $231.20M 10-Q · filed 2016-04-27 | |
| 2015-12-31 | $221.20M 10-K · filed 2019-02-21 | |
| 2015-09-30 | $193.30M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $170.70M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $148.60M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $140.20M 10-K · filed 2018-02-27 | |
| 2014-09-30 | $115.00M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $99.60M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $90.00M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $84.10M 10-K · filed 2017-02-28 | |
| 2013-09-30 | $74.70M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $72.30M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $73.60M 10-Q · filed 2013-05-01 | |
| 2012-12-31 | $77.00M 10-K · filed 2016-02-23 | |
| 2012-09-30 | $80.25M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $91.31M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $99.55M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $104.50M 10-K · filed 2015-02-25 | $104.49M 10-K · filed 2012-02-23 |
| 2011-09-30 | $113.06M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $121.58M 10-Q · filed 2011-08-03 | |
| 2010-12-31 | $61.00M 10-K · filed 2014-02-20 | $60.99M 10-Q · filed 2011-08-03 |
| 2009-12-31 | -$18.40M 10-K · filed 2013-02-21 | -$18.45M 10-K · filed 2012-02-23 |
| 2008-12-31 | -$19.47M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |